MACROGENICS INC — Director's Dealing 2014

Feb 18, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2014-02-18

Reporting Person: HURWITZ EDWARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-18	Common Stock	S	308513	$36.50	Disposed	1704996	Indirect

Footnotes

F1: These securities were sold as follows: 282,573 by Alta BioPharma Partners III, L.P. ("ABP III"), 18,977 by Alta BioPharma Partners III LP GmbH ("ABP III KG") and 6,963 by Alta Embarcadero BioPharma Partners III, LLC ("AEBP III"). Edward Hurwitz is a director of Alta BioPharma Management Partners III, LLC, which is the general partner of ABP III, the managing limited partner of ABP III KG and the manager of AEBP III.

F2: The shares are held as follows: 1,561,635 by ABPIII; 104,877 by ABPIII KG; and 38,484 by AEBP III. Edward Hurwitz disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.